T
Timothy T. Cornell
Researcher at Stanford University
Publications - 73
Citations - 4265
Timothy T. Cornell is an academic researcher from Stanford University. The author has contributed to research in topics: Medicine & Extracorporeal membrane oxygenation. The author has an hindex of 26, co-authored 61 publications receiving 3227 citations. Previous affiliations of Timothy T. Cornell include Lucile Packard Children's Hospital & University of Michigan.
Papers
More filters
Journal ArticleDOI
Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine*
Joe Brierley,Joseph A. Carcillo,Karen Choong,Timothy T. Cornell,Allan deCaen,Andreas J. Deymann,Allan Doctor,Alan L. Davis,John Duff,Marc Andre Dugas,Alan W. Duncan,Barry Evans,Jonathan D. Feldman,Kathryn Felmet,Gene Fisher,Lorry R. Frankel,Howard E. Jeffries,Bruce M. Greenwald,Juan Gutierrez,Mark W. Hall,Yong Y. Han,James Hanson,Jan A. Hazelzet,Lynn J. Hernan,Jane Kiff,Niranjan Kissoon,Alexander A. Kon,Jose Irazusta,John C. Lin,Angie Lorts,Michelle Mariscalco,Renuka Mehta,Simon Nadel,Trung Nguyen,Carol Nicholson,Mark J. Peters,Regina Okhuysen-Cawley,Tom Poulton,Monica Relves,Agustin Rodriguez,Ranna A. Rozenfeld,Eduardo Schnitzler,Tom Shanley,Sara Skache,Peter Skippen,Adalberto Torres,Bettina Von Dessauer,Jacki Weingarten,Timothy S. Yeh,Arno Zaritsky,Bonnie J. Stojadinovic,Jerry J. Zimmerman,Aaron L. Zuckerberg +52 more
TL;DR: The 2007 update of the 2002 American College of Critical Care Medicine Clinical Guidelines for Hemodynamic Support of Neonates and Children with Septic Shock continues to emphasize early use of age-specific therapies to attain time-sensitive goals, and a major new recommendation in the 2007 update is earlier use of inotrope support through peripheral access until central access is attained.
Journal ArticleDOI
American College of Critical Care Medicine Clinical Practice Parameters for Hemodynamic Support of Pediatric and Neonatal Septic Shock.
Alan L. Davis,Joseph A. Carcillo,Rajesh K. Aneja,Andreas J. Deymann,John C. Lin,Trung C. Nguyen,Regina Okhuysen-Cawley,Monica S. Relvas,Ranna A. Rozenfeld,Peter Skippen,Bonnie J. Stojadinovic,Eric A. Williams,Tim S. Yeh,Fran Balamuth,Joe Brierley,Allan R. de Caen,Ira M. Cheifetz,Karen Choong,Edward E. Conway,Timothy T. Cornell,Allan Doctor,Marc Andre Dugas,Jonathan D. Feldman,Julie C. Fitzgerald,Heidi R. Flori,James D. Fortenberry,Ana Lia Graciano,Bruce M. Greenwald,Mark W. Hall,Yong Yun Han,Lynn J. Hernan,Jose Irazuzta,Elizabeth Iselin,Elise W. van der Jagt,Howard E. Jeffries,Saraswati Kache,Chhavi Katyal,Niranjan Kissoon,Alexander A. Kon,Martha C. Kutko,Graeme MacLaren,Graeme MacLaren,Timothy M. Maul,Renuka Mehta,Fola Odetola,Kristine A Parbuoni,Raina Paul,Mark J. Peters,Suchitra Ranjit,Karin Reuter-Rice,Eduardo Schnitzler,Halden F. Scott,Adalberto Torres,Jacki Weingarten-Abrams,Scott L. Weiss,Jerry J. Zimmerman,Aaron L. Zuckerberg +56 more
TL;DR: A major new recommendation in the 2014 update of the 2007 American College of Critical Care Medicine “Clinical Guidelines for Hemodynamic Support of Neonates and Children with Septic Shock” is consideration of institution—specific use of a recognition bundle containing a trigger tool for rapid identification of patients with septic shock.
Journal ArticleDOI
Multiplex serum cytokine immunoassay using nanoplasmonic biosensor microarrays.
Pengyu Chen,Meng Ting Chung,Walker M. McHugh,Robert Nidetz,Yuwei Li,Jianping Fu,Timothy T. Cornell,Thomas P. Shanley,Katsuo Kurabayashi +8 more
TL;DR: A high-throughput, label-free, multiarrayed LSPR optical biosensor device with 480 nanoplasmonic sensing spots in microfluidic channel arrays is developed and the ability to monitor the inflammatory responses of infants following cardiopulmonary bypass (CPB) surgery through tracking the time-course variations of their serum cytokines is demonstrated.
Journal ArticleDOI
GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas
Robbie G. Majzner,Sneha Ramakrishna,Kristen W. Yeom,Shabnum Patel,Harshini Chinnasamy,Liora M. Schultz,Rebecca Richards,Li Jiang,Valentin Barsan,Rebecca A Mancusi,Anna Geraghty,Zina Good,Aaron Mochizuki,Shawn M. Gillespie,Angus Toland,Jasia Mahdi,Agnes Reschke,Esther H Nie,Isabelle J. Chau,Maria Caterina Rotiroti,Christopher Mount,Christina Baggott,Sharon Mavroukakis,Emily Egeler,Jennifer Moon,Courtney Erickson,Sean Green,Michael Kunicki,Michelle Fujimoto,Zach Ehlinger,Warren D. Reynolds,Sreevidya Kurra,Katherine E. Warren,Snehit Prabhu,Hannes Vogel,Lindsey Rasmussen,Timothy T. Cornell,Sonia Partap,Paul B. Fisher,Cynthia J. Campen,Mariella G. Filbin,Gerald A. Grant,Bita Sahaf,Kara L. Davis,Steven R. Feldman,Crystal L. Mackall,Michelle Monje +46 more
TL;DR: In this paper , the clinical experience from the first four patients with H3K27M-mutated diffuse midline glioma (DIPG) or spinal cord DMG treated with GD2-CAR T cells at dose level 1 (1 × 106 GD2 CAR T cells per kg administered intravenously).
Journal ArticleDOI
GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas
Robbie G. Majzner,Sneha Ramakrishna,Kristen W. Yeom,Shabnum Patel,Harshini Chinnasamy,Liora M. Schultz,Rebecca Richards,Li Jiang,Valentin Barsan,Rebecca A Mancusi,Anna Geraghty,Zina Good,Aaron Mochizuki,Shawn M. Gillespie,Angus Toland,Jasia Mahdi,Agnes Reschke,Esther H Nie,Isabelle J. Chau,Maria Caterina Rotiroti,Christopher Mount,Christina Baggott,Sharon Mavroukakis,Emily Egeler,Jennifer Moon,Courtney Erickson,Sean Green,Michael Kunicki,Michelle Fujimoto,Zach Ehlinger,Warren D. Reynolds,Sreevidya Kurra,Katherine E. Warren,Snehit Prabhu,Hannes Vogel,Lindsey Rasmussen,Timothy T. Cornell,Sonia Partap,Paul B. Fisher,Cynthia J. Campen,Mariella G. Filbin,Gerald A. Grant,Bita Sahaf,Kara L. Davis,Steven A. Feldman,Crystal L. Mackall,Michelle Monje +46 more
TL;DR: In this paper , the clinical experience from the first four patients with H3K27M-mutated diffuse midline glioma (DIPG) or spinal cord DMG treated with GD2-CAR T cells at dose level 1 (1 × 106 GD2 CAR T cells per kg administered intravenously).